REGULATORY INTELLIGENCE·Recall
Glenmark Pharmaceuticals Initiates US Nationwide Recall of Viorele Due to Impurity Failures
Glenmark Pharmaceuticals Inc., USA has initiated a Class II recall of 26,928 packs of Viorele (Desogestrel and Ethinyl Estradiol) across the US due to failed impurity and degradation specifications. This voluntary action impacts supply stability for a critical oral contraceptive, necessitating immediate review of procurement strategies and alternative sourcing options for affected stakeholders in the pharmaceutical supply chain.
90-Day Activity